MSB 10.4% $1.49 mesoblast limited

Australian newspaper article, page-140

  1. 5,491 Posts.
    lightbulb Created with Sketch. 8962
    This all may seem unfamiliar and uncharted territory… but there is some value in looking at other similar stories to what Meso has been and is going through right now.

    one such company is Amacus Therapeutics, have a look at the their pathway to approval for Galafold. Whilst not a biologic, the pathway to approval strikes many similarities to what we are going through now.

    and worth to note, if we get approval for ryoncil… we will get an insight into all the FDA correspondence (albeit redacted) which will be made public… that will be quite the read.

    goodluck all
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.49
Change
0.140(10.4%)
Mkt cap ! $1.701B
Open High Low Value Volume
$1.37 $1.54 $1.37 $23.10M 15.82M

Buyers (Bids)

No. Vol. Price($)
3 24758 $1.49
 

Sellers (Offers)

Price($) Vol. No.
$1.49 73626 3
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.